SPONSOR
Aplagon Oy
Total Trials
1
Recruiting
1
Phases
EARLY_Phase 1
Aplagon Oy is a clinical research sponsor with 1 registered studies on ClinicalTrials.gov, of which 1 are actively recruiting participants. Research covers conditions including Peripheral Arterial Occlusive Disease, Critical Limb Ischemia.
The trial portfolio spans EARLY_Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Aplagon Oy
How many clinical trials has Aplagon Oy sponsored?
ClinicalMetric currently tracks 1 clinical trials sponsored by Aplagon Oy, of which 1 are actively recruiting participants. These trials cover conditions including Peripheral Arterial Occlusive Disease, Critical Limb Ischemia. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Aplagon Oy research focus on?
Aplagon Oy clinical trials span Peripheral Arterial Occlusive Disease, Critical Limb Ischemia. The research pipeline includes EARLY_Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Aplagon Oy clinical trial?
To participate in a Aplagon Oy trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Aplagon Oy trials with current recruitment status updated daily.
Clinical Trials by Aplagon Oy
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology